|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.86 CHF | +69.18% |
|
+57.76% | +69.18% |
| 07-16 | Kalshi to allow bets on clinical trials, FDA decisions | RE |
| 07-15 | African markets - factors to watch on July 15 | RE |
| Market Cap | 167B 146B 135B 124B 234B 16,050B 239B 1,608B 632B 7,859B 626B 612B 27,067B | P/E 2026 * |
-48.4x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 176B 154B 142B 131B 247B 16,961B 252B 1,699B 667B 8,305B 662B 647B 28,603B | EV / Sales 2026 * |
5.78x | EV / Sales 2027 * | 5.15x |
| Free-Float |
99.88% | Yield 2026 * |
2.42% | Yield 2027 * | 2.5% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +69.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +69.18% | +57.76% | - | - | 169B | |
| +0.85% | -3.11% | +49.29% | +162.34% | 1,043B | |
| +1.23% | -2.34% | +53.56% | +58.28% | 602B | |
| +0.04% | +1.83% | +33.53% | +87.11% | 449B | |
| +0.78% | -0.39% | +30.44% | +23.23% | 327B | |
| +1.41% | +0.56% | +31.41% | +47.13% | 279B | |
| -0.27% | -5.69% | +20.68% | +21.99% | 264B | |
| -1.42% | +0.73% | +22.50% | +61.06% | 201B | |
| -0.36% | +3.30% | +1.79% | -31.03% | 143B | |
| -0.08% | -2.19% | +3.43% | +37.68% | 123B | |
| Average | +6.90% | -1.04% | +27.40% | +51.98% | 381.24B | |
| Weighted average by Cap. | +3.20% | -1.97% | +37.33% | +82.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.47B 26.64B 24.59B 22.65B 42.71B 2,933B 43.65B 294B 115B 1,436B 114B 112B 4,947B | 32.4B 28.33B 26.14B 24.08B 45.42B 3,119B 46.42B 312B 123B 1,527B 122B 119B 5,260B |
| Net income | -3.39B -2.96B -2.74B -2.52B -4.75B -326B -4.86B -32.71B -12.85B -160B -12.73B -12.45B -551B | 9.76B 8.54B 7.88B 7.26B 13.68B 940B 13.99B 94.15B 36.98B 460B 36.66B 35.85B 1,585B |
| Net Debt | 9.46B 8.27B 7.63B 7.03B 13.26B 911B 13.55B 91.24B 35.84B 446B 35.53B 34.74B 1,536B | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
- 000935700 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
